Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $13.1700 (1.78%) ($12.8800 - $13.2900) on Wed. Jul. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 53 | Latest Price | $13.1700(1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.3% a day on average for past five trading days. | Weekly Trend | HALO declines -2.5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.185% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-3%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
Resistance Level | $13.56 | 5 Day Moving Average | $13.09(0.61%) | 10 Day Moving Average | $13.79(-4.5%) | 20 Day Moving Average | $13.56(-2.88%) | To recent high | -11.6% | To recent low | 11.6% | Market Cap | $1.8b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |